ADAR antibody (AA 1116-1176)
Quick Overview for ADAR antibody (AA 1116-1176) (ABIN264971)
Target
See all ADAR AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1116-1176
-
Specificity
- This antibody reacts to DRADA.
-
Purification
- Purified
-
Immunogen
- GST fusion protein containing amino acid 1116-1176 of the rat DRADA coding sequence. The fusion protein was constructed in the pGEX-KG vector by inserting a fragment corresponding to nucleotides +3346 through +3525 of DRADA at the XbaI and XhoI sites in the vector.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: 1: 1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- Phosphate buffered saline with 0.08 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
-
- ADAR (Adenosine Deaminase, RNA-Specific (ADAR))
-
Alternative Name
- ADAR1 / DRADA
-
Background
- Double stranded RNA specific adenosine deaminase 1 (ADAR1 or DRADA) is an enzyme involved in the editing of mammalian messenger RNAs by the site specific conversion of adenosine to inosine. ADAR 1 is thought to play a role in the editing of transcripts encoding non-NMDA glutamate receptor subunits, the 2C subtype of serotonin receptor, as well as hepatitis delta virus antigen.Synonyms: 136 kDa double-stranded RNA-binding protein, DSRAD, Double-stranded RNA-specific adenosine deaminase, G1P1, IFI4, Interferon-inducible protein 4, K88DSRBP, P136
-
Gene ID
- 81635
-
NCBI Accession
- NP_112268
-
UniProt
- P55266
-
Pathways
- Protein targeting to Nucleus
Target
-